Cancer Immunotherapy
Navigating the Translational Future of Cancer Care with ASCO 2026 Late-Breaking Abstracts
2026-06-02
The Next Decade in Cancer Therapeutics: How Immunotherapy is Evolving from Efficacy to Precision
2026-05-05
AI Uncovers Adult Thymus as a Master Regulator of Cancer Immunotherapy Efficacy and Longevity
2026-04-15
AbbVie Bets $5.6 Billion on PD-1×VEGF Bispecifics, Licensing RemeGen’s RC148 to Expand Its Oncology Arsenal
2026-01-13
Teaching the Immune System When to Say “Yes” or “No”: Nobel Laureate Dr. Shimon Sakaguchi’s Treg Discovery in Cancer, Autoimmunity, and Drug Development
2025-10-19
Pilatus Biosciences Advances CD36 Metabolic Checkpoint to Revolutionize Tumor Microenvironment Cancer Therapy
2025-09-03
Redefining Immune Activation: A Strategy for Safer, Scalable Bispecific Cancer Therapeutics
2025-07-14
LATEST
EVENT
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan







